Solasta Bio

Overview
News
Biopesticides?
Product stageSegments
Minimum Viable Product
?
Biochemical Pesticides
?

Solasta Bio is a Glasgow-based agritech company specializing in the development of peptide-based bioinsecticides for crop protection. Founded in 2020 as a spin-out from the University of Glasgow, the company has created the world's first technology platform for producing neuropeptide-based Insect Control Agents (ICAs) derived from nature rather than synthetic chemistry.

These ICAs are designed to disrupt targeted physiological processes in insect pests, effectively controlling them while leaving beneficial pollinators like bees and other non-target species unharmed. Solasta Bio's solutions offer unique insect specificity, proven efficacy on par with traditional chemical insecticides, and an environmentally friendly, biodegradable approach that does not accumulate residues in nature.

Solasta Bio's platform enables the company to target a wide spectrum of pests, including those resistant to synthetic chemistries. The company aims to bring its first ICA products to market by 2027/2028, approximately half the time traditionally required for synthetic pest control products. Its technology is patent-protected, and an additional patent application is pending.

In February 2024, Solasta Bio announced the successful completion of over 20 field trials across Europe, the UK, and the US, demonstrating the efficacy and safety of its ICAs across various crops and pests, including aphids, Spotted Wing Drosophila, caterpillars, and leafhoppers.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
Institute of Molecular, Cell & Systems Biology University of Glasgow Glasgow GBR
Founded year:
2020
Employees:
11-50
IPO status:
Private
Total funding:
USD 21.7 mn
Last Funding:
USD 14.0 mn (Series A; Sep 2024)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.